Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹5 Cr
P/E Ratio
144.67
P/B Ratio
1.26
Industry P/E
44.82
Debt to Equity
0.31
ROE
0.87 %
ROCE
1.76 %
Div. Yield
0 %
Book Value
19.73
EPS
0.17
CFO
₹-1.17 Cr
EBITDA
₹0.95 Cr
Net Profit
₹0.19 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Fabino Life Sci
| -24.62 | -14.34 | -17.47 | -- | -1.56 | -- | -- |
|
BSE Healthcare*
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap#
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2,251.25 | 5,596.64 | 80.87 | 43.52 | |
| 329.40 | 396.35 | 582.01 | 1.68 | |
| 139.40 | 219.48 | 34.81 | 99.24 | |
| 112.00 | 117.75 | 59.46 | 4.82 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
2011
Chairman
--
Managing Director
Aditya Jain
Headquarters
Sonipat, Haryana
Website
Looking for more details about Fabino Life Sciences Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Fabino Life Sciences Ltd stood at ₹ 15 Cr as on 31-Mar-24
The share price of Fabino Life Sciences Ltd is ₹24.80 (BSE) as of 07-Apr-2025 IST. Fabino Life Sciences Ltd has given a return of -1.56% in the last 3 years.
Fabino Life Sciences Ltd has a market capitalisation of ₹ 5 Cr as on 07-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Fabino Life Sciences Ltd is 1.26 times as on 07-Apr-2025, a 69% discount to its peers’ median range of 4.07 times.
The P/E ratio of Fabino Life Sciences Ltd is 144.67 times as on 07-Apr-2025, a 223% premium to its peers’ median range of 44.82 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Fabino Life Sciences Ltd and enter the required number of quantities and click on buy to purchase the shares of Fabino Life Sciences Ltd.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
The promoters of Fabino Life Sciences Ltd are ADITYA MAHAVIR JAIN and VANDANA JAIN. They collectively own 56.38 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Fabino Life Sciences Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
5,597
|
|
|
396
|
|
|
219
|
|
|
118
|
| Fabino Life Sciences Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
0.87
|
|
Operating margin(%)
|
0.36
|
|
Net Margin(%)
|
0.17
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Fabino Life Sciences Ltd was ₹0 Cr.
₹0.30
(
